{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T10:44:16Z","timestamp":1784025856771,"version":"3.55.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s10384-025-01207-1","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T03:11:05Z","timestamp":1746846665000},"page":"732-737","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Factors predictive of treatment outcomes in submacular hemorrhage secondary to age-related macular degeneration"],"prefix":"10.1007","volume":"69","author":[{"given":"Yuto","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Koto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoka","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle A.","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8795-6536","authenticated-orcid":false,"given":"Keiko","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,10]]},"reference":[{"key":"1207_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/00006982-199616030-00001","volume":"16","author":"RL Avery","year":"1996","unstructured":"Avery RL, Fekrat S, Hawkins BS, Bressler NM. Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina. 1996;16:183\u20139.","journal-title":"Retina"},{"key":"1207_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000027400","volume":"213","author":"A Scupola","year":"1999","unstructured":"Scupola A, Coscas G, Soubrane G, Balestrazzi E. Natural history of macular subretinal hemorrhage in age-related macular degeneration. Ophthalmologica. 1999;213:97\u2013102.","journal-title":"Ophthalmologica"},{"key":"1207_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0039-6257(97)00089-1","volume":"42","author":"MA Hochman","year":"1997","unstructured":"Hochman MA, Seery CM, Zarbin MA. Pathophysiology and management of subretinal hemorrhage. Surv Ophthalmol. 1997;42:195\u2013213.","journal-title":"Surv Ophthalmol"},{"key":"1207_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115572","volume":"167","author":"S Chhatwal","year":"2023","unstructured":"Chhatwal S, Antony H, Lamei S, Kovacs-Oller T, Klettner AK, Zille M. A systematic review of the cell death mechanisms in retinal pigment epithelium cells and photoreceptors after subretinal hemorrhage - Implications for treatment options. Biomed Pharmacother. 2023;167: 115572.","journal-title":"Biomed Pharmacother"},{"key":"1207_CR5","unstructured":"Heriot WJ. Intravitreal gas and tPA: an outpatient procedure for submacular hemorrhage. Vail Vitrectomy Meeting; Vail, CO, 1996."},{"key":"1207_CR6","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1001\/archopht.116.10.1326","volume":"116","author":"M Ohji","year":"1998","unstructured":"Ohji M, Saito Y, Hayashi A, Lewis JM, Tano Y. Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator. Arch Ophthalmol. 1998;116:1326\u201332.","journal-title":"Arch Ophthalmol"},{"key":"1207_CR7","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1016\/S0161-6420(99)90399-8","volume":"106","author":"AS Hassan","year":"1999","unstructured":"Hassan AS, Johnson MW, Schneiderman TE, Regillo CD, Tornambe PE, Poliner LS, et al. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology. 1999;106:1900.","journal-title":"Ophthalmology"},{"key":"1207_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0002-9394(00)00734-0","volume":"131","author":"CL Haupert","year":"2001","unstructured":"Haupert CL, McCuen BW 2nd, Jaffe GJ, Steuer ER, Cox TA, Toth CA, et al. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration. Am J Ophthalmol. 2001;131:208\u201315.","journal-title":"Am J Ophthalmol"},{"key":"1207_CR9","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.ophtha.2003.10.020","volume":"111","author":"S Olivier","year":"2004","unstructured":"Olivier S, Chow DR, Packo KH, MacCumber MW, Awh CC. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in age-related macular degeneration. Ophthalmology. 2004;111:1201\u20138.","journal-title":"Ophthalmology"},{"key":"1207_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/01.iae.0000237586.48231.75","volume":"27","author":"CY Chen","year":"2007","unstructured":"Chen CY, Hooper C, Chiu D, Chamberlain M, Karia N, Heriot WJ. Management of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gas. Retina. 2007;27:321\u20138.","journal-title":"Retina"},{"key":"1207_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/IAE.0000000000003294","volume":"42","author":"GWM Chew","year":"2022","unstructured":"Chew GWM, Ivanova T, Patton N, Dhawahir-Scala F, Jasani KM, Turner G, et al. Step-wise approach to the management of submacular hemorrhage using pneumatic displacement and vitrectomy: the manchester protocol. Retina. 2022;42:11\u20138.","journal-title":"Retina"},{"key":"1207_CR12","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0161-6420(01)00648-0","volume":"108","author":"LO Hattenbach","year":"2001","unstructured":"Hattenbach LO, Klais C, Koch FH, Gumbel HO. Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions. Ophthalmology. 2001;108:1485\u201392.","journal-title":"Ophthalmology"},{"key":"1207_CR13","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/eye.2016.65","volume":"30","author":"JJ Gonzalez-Lopez","year":"2016","unstructured":"Gonzalez-Lopez JJ, McGowan G, Chapman E, Yorston D. Vitrectomy with subretinal tissue plasminogen activator and ranibizumab for submacular haemorrhages secondary to age-related macular degeneration: retrospective case series of 45 consecutive cases. Eye (Lond). 2016;30:929\u201335.","journal-title":"Eye (Lond)"},{"key":"1207_CR14","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.3390\/jcm9103088","volume":"9","author":"S Jeong","year":"2020","unstructured":"Jeong S, Park DG, Sagong M. Management of a submacular hemorrhage secondary to age-related macular degeneration: a comparison of three treatment modalities. J Clin Med. 2020;9:3088.","journal-title":"J Clin Med"},{"key":"1207_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168474","volume":"11","author":"K Bae","year":"2016","unstructured":"Bae K, Cho GE, Yoon JM, Kang SW. Optical coherence tomographic features and prognosis of pneumatic displacement for submacular hemorrhage. PLoS ONE. 2016;11: e0168474.","journal-title":"PLoS ONE"},{"key":"1207_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0274508","volume":"17","author":"T Kimura","year":"2022","unstructured":"Kimura T, Araki T, Yasukawa T, Kato A, Kuwayama S, Kinoshita T, et al. Differences in clinical characteristics and treatment outcomes of submacular hemorrhage caused by age-related macular degeneration and retinal macroaneurysms: a multicenter survey from the Japan Clinical Retina Study (J-CREST) group. PLoS ONE. 2022;17: e0274508.","journal-title":"PLoS ONE"},{"key":"1207_CR17","doi-asserted-by":"publisher","first-page":"5787","DOI":"10.3390\/jcm10245787","volume":"10","author":"M Pierre","year":"2021","unstructured":"Pierre M, Mainguy A, Chatziralli I, Pakzad-Vaezi K, Ruiz-Medrano J, Bodaghi B, et al. Macular hemorrhage due to age-related macular degeneration or retinal arterial macroaneurysm: predictive factors of surgical outcome. J Clin Med. 2021;10:5787.","journal-title":"J Clin Med"},{"key":"1207_CR18","doi-asserted-by":"publisher","first-page":"22139","DOI":"10.1038\/s41598-022-26289-6","volume":"12","author":"M Ogata","year":"2022","unstructured":"Ogata M, Oh H, Nakata A, Doi A, Nakayama H, Hasegawa M, et al. Displacement of submacular hemorrhage secondary to age-related macular degeneration with subretinal injection of air and tissue plasminogen activator. Sci Rep. 2022;12:22139.","journal-title":"Sci Rep"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-025-01207-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-025-01207-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-025-01207-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T13:37:29Z","timestamp":1757165849000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-025-01207-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,10]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1207"],"URL":"https:\/\/doi.org\/10.1007\/s10384-025-01207-1","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,10]]},"assertion":[{"value":"14 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y. Watanabe, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Chugai); T. Koto, Grants or contracts to the author\u2019s institution (Alcon), Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Santen, Bayer, Novartis, Kowa, Senju, AMO, Alcon, Chugai, Riverfield, Rohto Nitten); A. Takahashi, None; M. Mizuno, Grants or contracts to the author\u2019s institution (Alcon), Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Novartis, Kowa, Alcon); T. Ishida, None; K. Nakajima, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (AMO); J. Takeuchi, Grants or contracts to the author\u2019s institution (AMO), Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Chugai, Novartis, Santen, Bayer, Senju); T. Yokoi, None; M. Nakayama, None; A. A. Okada, Grants or contracts to the author\u2019s institution (Alcon, Bayer, Mitsubishi Tanabe, Pfizer, Santen), Consulting fees (Allergan, Apellis, Astellas, Bayer, Biocon Biologics, Chugai, Daiichi-Sankyo, Kowa), Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Bayer, Chugai, Kowa, Mitsubishi Tanabe, Novartis, Otsuka, Santen, Senju), Support for attending meetings and\/or travel (Bayer), Participation on a Data Safety Monitoring Board or Advisory Board (Bayer, Chugai); M. Inoue, Research grant (Santen, Alcon), Consulting fees (Alcon, ZEISS), Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Alcon, Santen, HOYA, Novartis, Chugai, ZEISS, Senju, Bayer, Logic & Design); K. Kataoka, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Chugai, Novartis, Santen, Bayer, Senju, Boehringer Ingelheim, Otsuka, Canon, ZEISS).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}